MariMed Inc. (OTCMKTS:MRMD) Short Interest Update

MariMed Inc. (OTCMKTS:MRMD) was the target of a large decline in short interest during the month of March. As of March 13th, there was short interest totaling 14,026 shares, a decline of 43.6% from the February 26th total of 24,883 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average trading volume of 679,274 shares, the days-to-cover ratio is currently 0.0 days.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded shares of MariMed from a “strong sell” rating to a “hold” rating in a research report on Thursday, January 1st. One research analyst has rated the stock with a Strong Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, MariMed currently has a consensus rating of “Moderate Buy”.

MariMed Stock Down 2.8%

Shares of OTCMKTS MRMD traded down $0.00 during mid-day trading on Friday, reaching $0.08. The company had a trading volume of 167,447 shares, compared to its average volume of 382,990. The company has a debt-to-equity ratio of 1.44, a quick ratio of 0.38 and a current ratio of 1.00. The company has a market capitalization of $30.15 million, a price-to-earnings ratio of -2.53 and a beta of 1.11. The stock has a fifty day moving average of $0.08 and a two-hundred day moving average of $0.11. MariMed has a 12-month low of $0.07 and a 12-month high of $0.23.

MariMed Company Profile

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.